These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 28870533

  • 1. Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus.
    Pavo-Blanco M, Novella-Navarro M, Cáliz-Cáliz R, Ferrer-González MA.
    Reumatol Clin (Engl Ed); 2018; 14(4):248-249. PubMed ID: 28870533
    [No Abstract] [Full Text] [Related]

  • 2. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
    So MW, Koo BS, Kim YJ, Kim YG, Lee CK, Yoo B.
    Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab in steroid refractory autoimmune hemolytic anemia.
    Gupta N, Sharma S, Seth T, Mishra P, Mahapatra M, Kumar S, Kapoor R, Agarwal N.
    Indian J Pediatr; 2012 Jun; 79(6):803-5. PubMed ID: 21830023
    [Abstract] [Full Text] [Related]

  • 10. Primary IgA-mediated Autoimmune Hemolytic Anemia in an Infant Successfully Treated With Rituximab.
    van den Akker M, Smolders D, Mahieu S, Bonouvrie K, van der Werf Ten Bosch J.
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e615-e619. PubMed ID: 32118812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of low-dose rituximab on hematological abnormalities in patients with connective tissue disease
.
    Wang CY, Guo SH, Wang LP, Wang XY, Shen HL.
    Int J Clin Pharmacol Ther; 2019 Oct; 57(10):500-505. PubMed ID: 31426902
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab.
    Poulet A, Jarrot PA, Mazodier K, Jean R, Kaplanski G.
    Lupus; 2019 Dec; 28(14):1735-1736. PubMed ID: 31610746
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus.
    Karageorgas T, Zomas A, Kazakou P, Katsimbri P, Mantzourani M, Boumpas D.
    Rheumatology (Oxford); 2016 Nov; 55(11):2085-2087. PubMed ID: 27342142
    [No Abstract] [Full Text] [Related]

  • 17. Cold haemagglutinin disease in systemic lupus erythematosus.
    Nair K, Pavithran K, Philip J, Thomas M, Geetha V.
    Yonsei Med J; 1997 Aug; 38(4):233-5. PubMed ID: 9339131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis.
    Tselios K, Lam WC, Urowitz MB, Gladman DD.
    J Clin Rheumatol; 2018 Mar; 24(2):93-94. PubMed ID: 29059086
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.